Cellectis S.A. ADR (CLLS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CLLS | EPRX | NAUT | ||
| Company | Cellectis S.A. ADR | Eupraxia Pharmaceuticals Inc | Nautilus Biotechnology Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 5.04 | 7.49 | 1.9600 | ||
| High | 5.10 | 7.83 | 2.0470 | ||
| Low | 4.82 | 7.28 | 1.9100 | ||
| Latest | 4.96 | 7.73 | 1.9400 | ||
| Change | +0.21 | +0.18 | -0.0400 | ||
| % Change | +4.42% | +2.38% | -2.02% | ||
| Volume | 105,000 | 272,000 | 139,300 | ||
| 20-Day Average Volume | 115,450 | 144,760 | 241,620 | ||
| Previous Close | 4.75 | 7.55 | 1.9800 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | No | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 4.66 | 6.46 | 1.9690 | ||
| 20-Day Raw Stochastic | 68.18% | 88.16% | 34.78% | ||
| 20-Day Relative Strength | 57.33 | 70.36 | 53.61 | ||
| Weighted Alpha | +184.99 | +154.30 | +51.90 | ||
| Today's Opinion | 100% Buy | 100% Buy | 80% Buy | ||
| Previous Opinion | 96% Buy | 100% Buy | 80% Buy | ||
| Last Month's Opinion | 100% Buy | 100% Buy | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +13.50% since 12/19/25 | +17.84% since 12/19/25 | unch since 12/19/25 | ||
| Low | 4.53 on 12/22/25 | 6.41 on 12/22/25 | 1.9100 on 12/29/25 | ||
| High | 5.10 on 12/29/25 | 8.00 on 12/26/25 | 2.0470 on 12/29/25 | ||
| 1-Month | |||||
| %Chg | -2.17% since 11/28/25 | +24.48% since 11/28/25 | -13.78% since 11/28/25 | ||
| Low | 3.91 on 12/17/25 | 5.72 on 12/02/25 | 1.7800 on 12/17/25 | ||
| High | 5.45 on 12/11/25 | 8.00 on 12/26/25 | 2.2400 on 12/01/25 | ||
| 3-Month | |||||
| %Chg | +74.65% since 09/29/25 | +34.43% since 09/29/25 | +141.83% since 09/29/25 | ||
| Low | 2.71 on 09/30/25 | 5.25 on 11/06/25 | 0.8001 on 09/30/25 | ||
| High | 5.48 on 10/16/25 | 8.00 on 12/26/25 | 2.5400 on 11/20/25 | ||
| 6-Month | |||||
| %Chg | +242.07% since 06/27/25 | +45.85% since 06/27/25 | +179.66% since 06/27/25 | ||
| Low | 1.42 on 06/30/25 | 4.88 on 07/22/25 | 0.6200 on 09/04/25 | ||
| High | 5.48 on 10/16/25 | 8.00 on 12/26/25 | 2.5400 on 11/20/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 264,005 | 271,506 | 250,084 | ||
| Shares Outstanding, K | 55,580 | 35,961 | 126,305 | ||
| Annual Sales | 49,220,000 | 0 | 0 | ||
| Annual Net Income | -36,760,000 | -25,500,000 | -70,780,000 | ||
| Last Quarter Sales | 37,160,000 | 0 | 0 | ||
| Last Quarter Net Income | 590,000 | -6,360,000 | -13,570,000 | ||
| 60-Month Beta | 2.82 | 1.38 | 1.48 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 0.01 on 11/07/25 | -0.19 on 11/04/25 | -0.11 on 10/27/25 | ||
| Latest Earnings Date | 03/12/26 | 03/19/26 | 02/25/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||